Pharmacology of the new target-specific oral anticoagulants

KP Cabral - Journal of thrombosis and thrombolysis, 2013 - Springer
Oral anticoagulation therapy is transforming with the advent of the target specific oral
anticoagulants, particularly, the direct thrombin inhibitors and factor Xa inhibitors. These …

Pharmacology of the new target-specific oral anticoagulants

KP Cabral - Journal of Thrombosis and Thrombolysis, 2013 - search.proquest.com
Pharmacology of the new target-specific oral anticoagulants Page 1 Pharmacology of the new
target-specific oral anticoagulants Katherine P. Cabral Published online: 5 May 2013 © Springer …

[引用][C] Pharmacology of the new target-specific oral anticoagulants

KP Cabral - Journal of Thrombosis and Thrombolysis, 2013 - cir.nii.ac.jp

Pharmacology of the new target-specific oral anticoagulants.

KP Cabral - Journal of Thrombosis and Thrombolysis, 2013 - europepmc.org
Oral anticoagulation therapy is transforming with the advent of the target specific oral
anticoagulants, particularly, the direct thrombin inhibitors and factor Xa inhibitors. These …

Pharmacology of the new target-specific oral anticoagulants

KP Cabral - Journal of Thrombosis and Thrombolysis, 2013 - infona.pl
Oral anticoagulation therapy is transforming with the advent of the target specific oral
anticoagulants, particularly, the direct thrombin inhibitors and factor Xa inhibitors. These …

Pharmacology of the new target-specific oral anticoagulants

KP Cabral - Journal of thrombosis and thrombolysis, 2013 - pubmed.ncbi.nlm.nih.gov
Oral anticoagulation therapy is transforming with the advent of the target specific oral
anticoagulants, particularly, the direct thrombin inhibitors and factor Xa inhibitors. These …

[引用][C] Pharmacology of the new target-specific oral anticoagulants

KP Cabral - Journal of thrombosis and thrombolysis, 2013 - Springer